Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the management of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://jonasooib148870.rimmablog.com/37832651/trelaglutide-exploring-a-new-treatment-for-chronic-diseases